APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 36 filers reported holding APTEVO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,634 | -77.4% | 11,013 | 0.0% | 0.00% | – |
| Q2 2023 | $16,079 | -28.3% | 11,013 | 0.0% | 0.00% | – |
| Q1 2023 | $22,412 | -14.6% | 11,013 | -2.7% | 0.00% | – |
| Q4 2022 | $26,246 | -54.0% | 11,313 | -39.9% | 0.00% | – |
| Q3 2022 | $57,000 | -28.8% | 18,814 | -15.5% | 0.00% | – |
| Q2 2022 | $80,000 | -73.3% | 22,272 | -56.4% | 0.00% | – |
| Q1 2022 | $300,000 | -66.0% | 51,096 | -54.4% | 0.00% | – |
| Q4 2021 | $883,000 | +419.4% | 112,155 | +917.0% | 0.00% | – |
| Q3 2021 | $170,000 | -9.1% | 11,028 | +31.9% | 0.00% | – |
| Q2 2021 | $187,000 | +92.8% | 8,364 | +163.4% | 0.00% | – |
| Q1 2021 | $97,000 | -18.5% | 3,175 | -2.3% | 0.00% | – |
| Q4 2020 | $119,000 | +3866.7% | 3,251 | +691.0% | 0.00% | – |
| Q3 2020 | $3,000 | -95.8% | 411 | -95.2% | 0.00% | – |
| Q2 2020 | $71,000 | +7000.0% | 8,558 | +2146.2% | 0.00% | – |
| Q1 2020 | $1,000 | – | 381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,334,169 | $440,276 | 0.32% |
| ARMISTICE CAPITAL, LLC | 1,235,000 | $407,550 | 0.01% |
| Divergent Wealth Advisors | 10,000 | $3,300 | 0.00% |
| FIFTH THIRD BANCORP | 291 | $96 | 0.00% |
| FRANKLIN RESOURCES INC | 10,997 | $3,629 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $2 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 142 | $47 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,562 | $515 | 0.00% |
| NORTHERN TRUST CORP | 14,121 | $4,660 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |